| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +60.00% | +5.30% | +1.25% | +4.05% | +1.46% | — |
| 14d | 10 | +80.00% | +9.01% | +2.07% | +6.94% | -5.00% | — |
| 30d | 10 | +80.00% | +10.38% | +1.32% | +9.06% | -7.24% | — |
| 60d | 10 | +80.00% | +9.24% | +4.40% | +4.84% | -15.93% | — |
| 90d | 10 | +80.00% | +3.16% | +6.70% | -3.54% | -23.89% | — |
| 180d | 10 | +60.00% | +5.53% | +11.55% | -8.45% | -14.29% | — |
| 1y | 10(2 pending) | +50.00% | +10.17% | +8.18% | +2.00% | -9.88% | — |
| 2y | 10(2 pending) | +87.50% | -17.94% | +7.89% | -25.84% | -31.94% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 233,840 | — | — | 233,840 | Jun 5, 2026 | Jun 9, 2026 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASE CMO | 2,357 | $4.24 | $10.0K | 2,357 | Nov 25, 2025 | Nov 25, 2025 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASE CMO | 589 | — | — | 589 | Nov 25, 2025 | Nov 25, 2025 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 325,000 | — | — | 325,000 | Mar 24, 2025 | Mar 26, 2025 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,407 | $17.12 | $24.1K | 47,614 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,500 | — | — | 49,021 | Aug 13, 2021 | Aug 17, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,250 | $13.81 | $17.3K | 44,521 | Jul 28, 2021 | Jul 29, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 375 | $19.46 | $7.3K | 45,594 | May 12, 2021 | May 13, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 375 | $19.14 | $7.2K | 45,969 | May 11, 2021 | May 13, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,125 | $31.58 | $35.5K | 46,344 | Feb 8, 2021 | Feb 9, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,125 | $31.41 | $35.3K | 47,469 | Feb 5, 2021 | Feb 9, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,500 | — | — | 48,594 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 563 | $28.91 | $16.3K | 44,094 | Feb 3, 2021 | Feb 3, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,250 | $28.91 | $36.1K | 44,657 | Feb 3, 2021 | Feb 3, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 563 | $30.75 | $17.3K | 45,907 | Feb 2, 2021 | Feb 2, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,250 | $30.75 | $38.4K | 46,470 | Feb 2, 2021 | Feb 2, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | — | — | 47,720 | Jan 31, 2021 | Feb 2, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 57,500 | — | — | 57,500 | Jan 21, 2021 | Jan 25, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 42,720 | Jan 21, 2021 | Jan 25, 2021 ↗ | View → |